Literature DB >> 27770164

Diffusion-weighted endorectal MR imaging at 3T for prostate cancer: correlation with tumor cell density and percentage Gleason pattern on whole mount pathology.

Daniel I Glazer1, Elmira Hassanzadeh2, Andriy Fedorov2, Olutayo I Olubiyi2, Shayna S Goldberger2, Tobias Penzkofer3, Trevor A Flood4,5, Paul Masry6, Robert V Mulkern7, Michelle S Hirsch8, Clare M Tempany2, Fiona M Fennessy2,9.   

Abstract

OBJECTIVE: To determine if tumor cell density and percentage of Gleason pattern within an outlined volumetric tumor region of interest (TROI) on whole-mount pathology (WMP) correlate with apparent diffusion coefficient (ADC) values on corresponding TROIs outlined on pre-operative MRI.
METHODS: Men with biopsy-proven prostate adenocarcinoma undergoing multiparametric MRI (mpMRI) prior to prostatectomy were consented to this prospective study. WMP and mpMRI images were viewed using 3D Slicer and each TROI from WMP was contoured on the high b-value ADC maps (b0, 1400). For each TROI outlined on WMP, TCD (tumor cell density) and the percentage of Gleason pattern 3, 4, and 5 were recorded. The ADCmean, ADC10th percentile, ADC90th percentile, and ADCratio were also calculated in each case from the ADC maps using 3D Slicer.
RESULTS: Nineteen patients with 21 tumors were included in this study. ADCmean values for TROIs were 944.8 ± 327.4 vs. 1329.9 ± 201.6 mm2/s for adjacent non-neoplastic prostate tissue (p < 0.001). ADCmean, ADC10th percentile, and ADCratio values for higher grade tumors were lower than those of lower grade tumors (mean 809.71 and 1176.34 mm2/s, p = 0.014; 10th percentile 613.83 and 1018.14 mm2/s, p = 0.009; ratio 0.60 and 0.94, p = 0.005). TCD and ADCmean (ρ = -0.61, p = 0.005) and TCD and ADC10th percentile (ρ = -0.56, p = 0.01) were negatively correlated. No correlation was observed between percentage of Gleason pattern and ADC values.
CONCLUSION: DWI MRI can characterize focal prostate cancer using ADCratio, ADC10th percentile, and ADCmean, which correlate with pathological tumor cell density.

Entities:  

Keywords:  ADC; DWI; Gleason pattern; MRI; Prostate cancer

Mesh:

Substances:

Year:  2017        PMID: 27770164      PMCID: PMC5357151          DOI: 10.1007/s00261-016-0942-1

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  40 in total

1.  A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial.

Authors:  Tineke Wolters; Monique J Roobol; Pim J van Leeuwen; Roderick C N van den Bergh; Robert F Hoedemaeker; Geert J L H van Leenders; Fritz H Schröder; Theodorus H van der Kwast
Journal:  J Urol       Date:  2010-11-12       Impact factor: 7.450

2.  Tissue shrinkage after fixation with formalin injection of prostatectomy specimens.

Authors:  Sara Jonmarker; Alexander Valdman; Anna Lindberg; Magnus Hellström; Lars Egevad
Journal:  Virchows Arch       Date:  2006-08-15       Impact factor: 4.064

3.  Cell density modulates the metastatic aggressiveness of a mouse colon cancer cell line, colon 26.

Authors:  Hiroyuki Kuwano; Tatsuya Miyazaki; Soichi Tsutsumi; Isao Hirayama; Tatsuo Shimura; Erito Mochiki; Ken-Ichi Nomoto; Minoru Fukuchi; Hiroyuki Kato; Takayuki Asao
Journal:  Oncology       Date:  2004       Impact factor: 2.935

4.  Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla.

Authors:  Peter Gibbs; Gary P Liney; Martin D Pickles; Bashar Zelhof; Greta Rodrigues; Lindsay W Turnbull
Journal:  Invest Radiol       Date:  2009-09       Impact factor: 6.016

5.  Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging.

Authors:  Aytekin Oto; Arda Kayhan; Yulei Jiang; Maria Tretiakova; Cheng Yang; Tatjana Antic; Farid Dahi; Arieh L Shalhav; Gregory Karczmar; Walter M Stadler
Journal:  Radiology       Date:  2010-09-15       Impact factor: 11.105

6.  Long-term prognostic significance of primary Gleason pattern in patients with Gleason score 7 prostate cancer: impact on prostate cancer specific survival.

Authors:  Matthew K Tollefson; Bradley C Leibovich; Jeffrey M Slezak; Horst Zincke; Michael L Blute
Journal:  J Urol       Date:  2006-02       Impact factor: 7.450

Review 7.  Imaging prostate cancer: a multidisciplinary perspective.

Authors:  Hedvig Hricak; Peter L Choyke; Steven C Eberhardt; Steven A Leibel; Peter T Scardino
Journal:  Radiology       Date:  2007-04       Impact factor: 11.105

8.  Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?

Authors:  Jennifer R Stark; Sven Perner; Meir J Stampfer; Jennifer A Sinnott; Stephen Finn; Anna S Eisenstein; Jing Ma; Michelangelo Fiorentino; Tobias Kurth; Massimo Loda; Edward L Giovannucci; Mark A Rubin; Lorelei A Mucci
Journal:  J Clin Oncol       Date:  2009-05-11       Impact factor: 44.544

9.  Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings.

Authors:  Yousef Mazaheri; Amita Shukla-Dave; Hedvig Hricak; Samson W Fine; Jingbo Zhang; Gloria Inurrigarro; Chaya S Moskowitz; Nicole M Ishill; Victor E Reuter; Karim Touijer; Kristen L Zakian; Jason A Koutcher
Journal:  Radiology       Date:  2008-02       Impact factor: 11.105

10.  Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer.

Authors:  Bashar Zelhof; Martin Pickles; Gary Liney; Peter Gibbs; Greta Rodrigues; Sigurd Kraus; Lindsay Turnbull
Journal:  BJU Int       Date:  2008-10-24       Impact factor: 5.588

View more
  12 in total

1.  Comparison of quantitative apparent diffusion coefficient parameters with prostate imaging reporting and data system V2 assessment for detection of clinically significant peripheral zone prostate cancer.

Authors:  Elmira Hassanzadeh; Francesco Alessandrino; Olutayo I Olubiyi; Daniel I Glazer; Robert V Mulkern; Andriy Fedorov; Clare M Tempany; Fiona M Fennessy
Journal:  Abdom Radiol (NY)       Date:  2018-05

Review 2.  Is perfect the enemy of good? Weighing the evidence for biparametric MRI in prostate cancer.

Authors:  Alexander P Cole; Bjoern J Langbein; Francesco Giganti; Fiona M Fennessy; Clare M Tempany; Mark Emberton
Journal:  Br J Radiol       Date:  2021-12-16       Impact factor: 3.039

3.  Multiparametric MRI Apparent Diffusion Coefficient (ADC) Accuracy in Diagnosing Clinically Significant Prostate Cancer.

Authors:  Pietro Pepe; Davide D'Urso; Antonio Garufi; Giandomenico Priolo; Michele Pennisi; Giorgio Russo; Maria Gabriella Sabini; Lucia Maria Valastro; Antonio Galia; Filippo Fraggetta
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

4.  Risk Stratification Among Men With Prostate Imaging Reporting and Data System version 2 Category 3 Transition Zone Lesions: Is Biopsy Always Necessary?

Authors:  Ely R Felker; Steven S Raman; Daniel J Margolis; David S K Lu; Nicholas Shaheen; Shyam Natarajan; Devi Sharma; Jiaoti Huang; Fred Dorey; Leonard S Marks
Journal:  AJR Am J Roentgenol       Date:  2017-08-31       Impact factor: 3.959

5.  Targeted Biopsy Validation of Peripheral Zone Prostate Cancer Characterization With Magnetic Resonance Fingerprinting and Diffusion Mapping.

Authors:  Ananya Panda; Gregory OʼConnor; Wei Ching Lo; Yun Jiang; Seunghee Margevicius; Mark Schluchter; Lee E Ponsky; Vikas Gulani
Journal:  Invest Radiol       Date:  2019-08       Impact factor: 6.016

Review 6.  [Multiparametric MRI of the prostate : Important radiological findings for urologists].

Authors:  Heinz-Peter Schlemmer
Journal:  Radiologe       Date:  2017-08       Impact factor: 0.635

7.  Multiparametric Magnetic Resonance Imaging of the Prostate: Repeatability of Volume and Apparent Diffusion Coefficient Quantification.

Authors:  Andriy Fedorov; Mark G Vangel; Clare M Tempany; Fiona M Fennessy
Journal:  Invest Radiol       Date:  2017-09       Impact factor: 6.016

8.  Correlation between apparent diffusion coefficient (ADC) and cellularity is different in several tumors: a meta-analysis.

Authors:  Alexey Surov; Hans Jonas Meyer; Andreas Wienke
Journal:  Oncotarget       Date:  2017-05-10

9.  A Pilot Study of Multidimensional Diffusion MRI for Assessment of Tissue Heterogeneity in Prostate Cancer.

Authors:  Björn J Langbein; Filip Szczepankiewicz; Carl-Fredrik Westin; Camden Bay; Stephan E Maier; Adam S Kibel; Clare M Tempany; Fiona M Fennessy
Journal:  Invest Radiol       Date:  2021-12-01       Impact factor: 6.016

10.  Discrimination between clinical significant and insignificant prostate cancer with apparent diffusion coefficient - a systematic review and meta analysis.

Authors:  Hans-Jonas Meyer; Andreas Wienke; Alexey Surov
Journal:  BMC Cancer       Date:  2020-05-27       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.